 | | 20B | | Name: | 2-(3-hydroxyphenyl)-4H-chromen-4-one | | Formula: | C15 H10 O3 | | SMILES: | O=C1c3c(OC(=C1)c2cccc(O)c2)cccc3 | | InChi: | InChI=1S/C15H10O3/c16-11-5-3-4-10(8-11)15-9-13(17)12-6-1-2-7-14(12)18-15/h1-9,16H | | Synonyms: | 3'-hydroxyflavone | | Definition date: | 2012-10-19 | | Last modified: | 2020-06-17 | | Release date: | 2012-10-26 | | Identifier: | 2-(3-hydroxyphenyl)-4H-chromen-4-one |
|
 | | 20C | | Name: | 2-hydroxy-4-(4-methyl-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)benzoic acid | | Formula: | C16 H11 N O5 | | SMILES: | O=C(O)c1ccc(cc1O)N3C(=O)c2cccc(c2C3=O)C | | InChi: | InChI=1S/C16H11NO5/c1-8-3-2-4-11-13(8)15(20)17(14(11)19)9-5-6-10(16(21)22)12(18)7-9/h2-7,18H,1H3,(H,21,22) | | Synonyms: | 2-hydroxy-4-(4-methyl-1,3-dioxo-2,3-dihydro-1H- isoindol-2-yl)benzoic acid | | Definition date: | 2009-08-06 | | Last modified: | 2020-06-17 | | Identifier: | 2-hydroxy-4-(4-methyl-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)benzoic acid |
|
 | | NEU | | Name: | L-NEOPTERIN | | Formula: | C9 H11 N5 O4 | | SMILES: | O=C1c2nc(cnc2N=C(N1)N)C(O)C(O)CO | | InChi: | InChI=1S/C9H11N5O4/c10-9-13-7-5(8(18)14-9)12-3(1-11-7)6(17)4(16)2-15/h1,4,6,15-17H,2H2,(H3,10,11,13,14,18)/t4-,6+/m1/s1 | | Synonyms: | 2-AMINO-6-((1S,2R)-1,2,3-TRIHYDROXYPROPYL)PTERIDIN-4(3H)-ONE | | Definition date: | 2004-08-20 | | Last modified: | 2020-06-17 | | Identifier: | 2-amino-6-[(1S,2R)-1,2,3-trihydroxypropyl]pteridin-4(3H)-one |
|
 | | NF | | Name: | N,N'-(3,7-DIAZANONYLENE)-BIS-NAPHTHALIMIDE | | Formula: | C31 H30 N4 O4 | | SMILES: | O=C3c1c2c(ccc1)cccc2C(=O)N3CC[NH2+]CCC[NH2+]CCN6C(=O)c5cccc4cccc(c45)C6=O | | InChi: | InChI=1S/C31H28N4O4/c36-28-22-10-1-6-20-7-2-11-23(26(20)22)29(37)34(28)18-16-32-14-5-15-33-17-19-35-30(38)24-12-3-8-21-9-4-13-25(27(21)24)31(35)39/h1-4,6-13,32-33H,5,14-19H2/p+2 | | Synonyms: | LU-79553 | | Definition date: | 1999-09-02 | | Last modified: | 2020-06-17 | | Identifier: | N,N'-bis[2-(1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)ethyl]propane-1,3-diaminium |
|
 | | 6UR | | Name: | [(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-~{N}-[2-(1~{H}-indol-3-yl)ethyl]p
hosphonamidic acid | | Formula: | C20 H24 N7 O6 P | | SMILES: | Nc1ncnc2n(cnc12)[CH]3O[CH](CO[P](O)(=O)NCCc4c[nH]c5ccccc45)[CH](O)[CH]3O | | InChi: | InChI=1S/C20H24N7O6P/c21-18-15-19(24-9-23-18)27(10-25-15)20-17(29)16(28)14(33-20)8-32-34(30,31)26-6-5-11-7-22-13-4-2-1-3-12(11)13/h1-4,7,9-10,14,16-17,20,22,28-29H,5-6,8H2,(H2,21,23,24)(H2,26,30,31)/t14-,16-,17-,20-/m1/s1 | | Synonyms: | TpAd | | Definition date: | 2016-06-28 | | Last modified: | 2020-06-17 | | Release date: | 2017-06-28 | | Identifier: | [(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-~{N}-[2-(1~{H}-indol-3-yl)ethyl]phosphonamidic acid |
|
 | | 6UT | | Name: | [(2~{R},3~{S},4~{R},5~{R})-5-(2-azanyl-6-oxidanylidene-1~{H}-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-~{N}-[(2~
{S})-3-(1~{H}-indol-3-yl)-1-(methylamino)-1-oxidanylidene-propan-2-yl]phosphonamidic acid | | Formula: | C22 H27 N8 O8 P | | SMILES: | CNC(=O)[CH](Cc1c[nH]c2ccccc12)N[P](O)(=O)OC[CH]3O[CH]([CH](O)[CH]3O)n4cnc5C(=O)NC(=Nc45)N | | InChi: | InChI=1S/C22H27N8O8P/c1-24-19(33)13(6-10-7-25-12-5-3-2-4-11(10)12)29-39(35,36)37-8-14-16(31)17(32)21(38-14)30-9-26-15-18(30)27-22(23)28-20(15)34/h2-5,7,9,13-14,16-17,21,25,31-32H,6,8H2,1H3,(H,24,33)(H2,29,35,36)(H3,23,27,28,34)/t13-,14+,16+,17+,21+/m0/s1 | | Synonyms: | L-Trp-G | | Definition date: | 2016-06-28 | | Last modified: | 2020-06-17 | | Release date: | 2017-06-28 | | Identifier: | [(2~{R},3~{S},4~{R},5~{R})-5-(2-azanyl-6-oxidanylidene-1~{H}-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-~{N}-[(2~{S})-3-(1~{H}-indol-3-yl)-1-(methylamino)-1-oxidanylidene-propan-2-yl]phosphonamidic acid |
|
 | | 6UZ | | Name: | omega-undecylenyl-beta-D-maltopyranoside | | Formula: | C23 H42 O11 | | SMILES: | OC[CH]1O[CH](O[CH]2[CH](O)[CH](O)[CH](OCCCCCCCCCC=C)O[CH]2CO)[CH](O)[CH](O)[CH]1O | | InChi: | InChI=1S/C23H42O11/c1-2-3-4-5-6-7-8-9-10-11-31-22-20(30)18(28)21(15(13-25)33-22)34-23-19(29)17(27)16(26)14(12-24)32-23/h2,14-30H,1,3-13H2/t14-,15-,16-,17+,18-,19-,20-,21-,22-,23-/m1/s1 | | Synonyms: | (2~{R},3~{S},4~{S},5~{R},6~{R})-2-(hydroxymethyl)-6-[(2~{R},3~{S},4~{R},5~{R},6~{R})-2-(hydroxymethyl)-4,5-bis(oxidanyl
)-6-undec-10-enoxy-oxan-3-yl]oxy-oxane-3,4,5-triol | | Definition date: | 2016-06-29 | | Last modified: | 2020-06-17 | | Release date: | 2017-03-22 | | Identifier: | (2~{R},3~{S},4~{S},5~{R},6~{R})-2-(hydroxymethyl)-6-[(2~{R},3~{S},4~{R},5~{R},6~{R})-2-(hydroxymethyl)-4,5-bis(oxidanyl)-6-undec-10-enoxy-oxan-3-yl]oxy-oxane-3,4,5-triol |
|
 | | NFD | | Name: | Nicotinamide 2-fluoro-adenine dinucleotide | | Formula: | C21 H26 F N7 O14 P2 | | SMILES: | NC(=O)c1ccc[n+](c1)[CH]2O[CH](CO[P]([O-])(=O)O[P](O)(=O)OC[CH]3O[CH]([CH](O)[CH]3O)n4cnc5c(N)nc(F)nc45)[CH](O)[CH]2O | | InChi: | InChI=1S/C21H26FN7O14P2/c22-21-26-16(23)11-18(27-21)29(7-25-11)20-15(33)13(31)10(42-20)6-40-45(37,38)43-44(35,36)39-5-9-12(30)14(32)19(41-9)28-3-1-2-8(4-28)17(24)34/h1-4,7,9-10,12-15,19-20,30-33H,5-6H2,(H5-,23,24,26,27,34,35,36,37,38)/t9-,10-,12-,13-,14-,15-,19-,20-/m1/s1 | | Synonyms: | 2-fluoro-NAD+ | | Definition date: | 2009-07-14 | | Last modified: | 2020-06-17 | | Identifier: | [(2R,3S,4R,5R)-5-(3-aminocarbonylpyridin-1-ium-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl [[(2R,3S,4R,5R)-5-(6-azanyl-2-fluoro-purin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphate |
|
 | | NFQ | | Name: | N-[(E)-iminomethyl]-L-aspartic acid | | Formula: | C5 H8 N2 O4 | | SMILES: | O=C(O)C(NC=[N@H])CC(=O)O | | InChi: | InChI=1S/C5H8N2O4/c6-2-7-3(5(10)11)1-4(8)9/h2-3H,1H2,(H2,6,7)(H,8,9)(H,10,11)/t3-/m0/s1 | | Synonyms: | N-formimino-L-Aspartate | | Definition date: | 2010-04-12 | | Last modified: | 2020-06-17 | | Identifier: | N-[(E)-iminomethyl]-L-aspartic acid |
|
 | | NFX | | Name: | 7-[(3R)-3-aminopyrrolidin-1-yl]-8-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | | Formula: | C17 H17 Cl F N3 O3 | | SMILES: | Fc2c(c(Cl)c1N(C=C(C(=O)O)C(=O)c1c2)C3CC3)N4CCC(N)C4 | | InChi: | InChI=1S/C17H17ClFN3O3/c18-13-14-10(5-12(19)15(13)21-4-3-8(20)6-21)16(23)11(17(24)25)7-22(14)9-1-2-9/h5,7-9H,1-4,6,20H2,(H,24,25)/t8-/m1/s1 | | Synonyms: | Clinafloxacin | | Definition date: | 2009-01-06 | | Last modified: | 2020-06-17 | | Identifier: | 7-[(3R)-3-aminopyrrolidin-1-yl]-8-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
|
 | | NFZ | | Name: | NITROFURAZONE | | Formula: | C6 H6 N4 O4 | | SMILES: | O=[N+]([O-])c1oc(/C=N/NC(=O)N)cc1 | | InChi: | InChI=1S/C6H6N4O4/c7-6(11)9-8-3-4-1-2-5(14-4)10(12)13/h1-3H,(H3,7,9,11)/b8-3+ | | Synonyms: | 5-NITRO-2-FURALDEHYDE SEMICARBAZONE | | Definition date: | 2005-01-27 | | Last modified: | 2020-06-17 | | Identifier: | 5-nitrofuran-2-carbaldehyde semicarbazone |
|
 | | NG7 | | Name: | 3-{2-[(cyclopropylcarbonyl)amino][1,3]thiazolo[5,4-b]pyridin-5-yl}-N-{4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromet
hyl)phenyl}benzamide | | Formula: | C31 H31 F3 N6 O2 S | | SMILES: | FC(F)(F)c1cc(ccc1CN2CCN(CC)CC2)NC(=O)c6cc(c3nc4sc(nc4cc3)NC(=O)C5CC5)ccc6 | | InChi: | InChI=1S/C31H31F3N6O2S/c1-2-39-12-14-40(15-13-39)18-22-8-9-23(17-24(22)31(32,33)34)35-28(42)21-5-3-4-20(16-21)25-10-11-26-29(36-25)43-30(37-26)38-27(41)19-6-7-19/h3-5,8-11,16-17,19H,2,6-7,12-15,18H2,1H3,(H,35,42)(H,37,38,41) | | Synonyms: | HG-7-85-01 | | Definition date: | 2012-02-02 | | Last modified: | 2020-06-17 | | Identifier: | 3-{2-[(cyclopropylcarbonyl)amino][1,3]thiazolo[5,4-b]pyridin-5-yl}-N-{4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide |
|
 | | 6VW | | Name: | (8~{R},9~{S},10~{R},13~{S},14~{S},17~{S})-13-methyl-17-oxidanyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1~{H}-cyclop
enta[a]phenanthren-3-one | | Formula: | C18 H26 O2 | | SMILES: | C[C]12CC[CH]3[CH](CCC4=CC(=O)CC[CH]34)[CH]1CC[CH]2O | | InChi: | InChI=1S/C18H26O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h10,13-17,20H,2-9H2,1H3/t13-,14+,15+,16-,17-,18-/m0/s1 | | Synonyms: | 19-nortestosterone | | Definition date: | 2016-07-06 | | Last modified: | 2020-06-17 | | Release date: | 2016-09-07 | | Identifier: | (8~{R},9~{S},10~{R},13~{S},14~{S},17~{S})-13-methyl-17-oxidanyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1~{H}-cyclopenta[a]phenanthren-3-one |
|
 | | NGB | | Name: | 4-nitrophenyl 6-O-beta-D-glucopyranosyl-beta-D-glucopyranoside | | Formula: | C18 H25 N O13 | | SMILES: | [O-][N+](=O)c3ccc(OC1OC(C(O)C(O)C1O)COC2OC(CO)C(O)C(O)C2O)cc3 | | InChi: | InChI=1S/C18H25NO13/c20-5-9-11(21)13(23)15(25)17(31-9)29-6-10-12(22)14(24)16(26)18(32-10)30-8-3-1-7(2-4-8)19(27)28/h1-4,9-18,20-26H,5-6H2/t9-,10-,11-,12-,13+,14+,15-,16-,17-,18-/m1/s1 | | Synonyms: | P-NITROPHENYL-GENTIOBIOSIDE | | Definition date: | 2013-08-13 | | Last modified: | 2020-06-17 | | Release date: | 2014-06-25 | | Identifier: | 4-nitrophenyl 6-O-beta-D-glucopyranosyl-beta-D-glucopyranoside |
|
 | | NGD | | Name: | 3-(AMINOCARBONYL)-1-[(2R,3R,4S,5R)-5-({[(S)-{[(S)-{[(2R,3S,4R,5R)-5-(2-AMINO-6-OXO-1,6-DIHYDRO-9H-PURIN-9-YL)-3,4-DIHYD
ROXYTETRAHYDROFURAN-2-YL]METHOXY}(HYDROXY)PHOSPHORYL]OXY}(HYDROXY)PHOSPHORYL]OXY}METHYL)-3,4-DIHYDROXYTETRAHYDROFURAN-2-
YL]PYRIDINIUM | | Formula: | C21 H28 N7 O15 P2 | | SMILES: | NC(=O)c1ccc[n+](c1)[CH]2O[CH](CO[P](O)(=O)O[P](O)(=O)OC[CH]3O[CH]([CH](O)[CH]3O)n4cnc5C(=O)NC(=Nc45)N)[CH](O)[CH]2O | | InChi: | InChI=1S/C21H27N7O15P2/c22-16(33)8-2-1-3-27(4-8)19-14(31)12(29)9(41-19)5-39-44(35,36)43-45(37,38)40-6-10-13(30)15(32)20(42-10)28-7-24-11-17(28)25-21(23)26-18(11)34/h1-4,7,9-10,12-15,19-20,29-32H,5-6H2,(H6-,22,23,25,26,33,34,35,36,37,38)/p+1/t9-,10-,12-,13-,14-,15-,19-,20-/m1/s1 | | Synonyms: | NICOTINAMIDE GUANINE DINUCLEOTIDE | | Definition date: | 2006-12-12 | | Last modified: | 2020-06-17 | | Identifier: | [[(2R,3S,4R,5R)-5-(3-aminocarbonylpyridin-1-ium-1-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] [(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl hydrogen phosphate |
|
 | | 6W7 | | Name: | [(3~{S},4~{R})-4-(6-oxidanylidene-1~{H}-purin-9-yl)pyrrolidin-3-yl]oxymethylphosphonic acid | | Formula: | C10 H14 N5 O5 P | | SMILES: | O[P](O)(=O)CO[CH]1CNC[CH]1n2cnc3C(=O)NC=Nc23 | | InChi: | InChI=1S/C10H14N5O5P/c16-10-8-9(12-3-13-10)15(4-14-8)6-1-11-2-7(6)20-5-21(17,18)19/h3-4,6-7,11H,1-2,5H2,(H,12,13,16)(H2,17,18,19)/t6-,7+/m1/s1 | | Synonyms: | [3S,4R]-(4-(Hypoxanthin-9-yl)pyrrolidin-3-yl)-oxymethanephosphonic acid | | Definition date: | 2016-07-08 | | Last modified: | 2020-06-17 | | Release date: | 2017-09-20 | | Identifier: | [(3~{S},4~{R})-4-(6-oxidanylidene-1~{H}-purin-9-yl)pyrrolidin-3-yl]oxymethylphosphonic acid |
|
 | | 6W8 | | Name: | [(3~{S},4~{R})-4-(2-azanyl-6-oxidanylidene-1~{H}-purin-9-yl)pyrrolidin-3-yl]oxymethylphosphonic acid | | Formula: | C10 H15 N6 O5 P | | SMILES: | NC1=Nc2n(cnc2C(=O)N1)[CH]3CNC[CH]3OC[P](O)(O)=O | | InChi: | InChI=1S/C10H15N6O5P/c11-10-14-8-7(9(17)15-10)13-3-16(8)5-1-12-2-6(5)21-4-22(18,19)20/h3,5-6,12H,1-2,4H2,(H2,18,19,20)(H3,11,14,15,17)/t5-,6+/m1/s1 | | Synonyms: | [3S,4R]-(4-(Guanin-9-yl)pyrrolidin-3-yl)oxymethanephosphonic acid | | Definition date: | 2016-07-08 | | Last modified: | 2020-06-17 | | Release date: | 2017-09-20 | | Identifier: | [(3~{S},4~{R})-4-(2-azanyl-6-oxidanylidene-1~{H}-purin-9-yl)pyrrolidin-3-yl]oxymethylphosphonic acid |
|
 | | NHE | | Name: | 2-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC ACID | | Formula: | C8 H17 N O3 S | | SMILES: | O=S(=O)(O)CCNC1CCCCC1 | | InChi: | InChI=1S/C8H17NO3S/c10-13(11,12)7-6-9-8-4-2-1-3-5-8/h8-9H,1-7H2,(H,10,11,12) | | Synonyms: | N-CYCLOHEXYLTAURINE | | Definition date: | 2001-04-24 | | Last modified: | 2020-06-17 | | Identifier: | 2-(cyclohexylamino)ethanesulfonic acid |
|
 | | NHQ | | Name: | (3R)-27-AMINO-3-HYDROXY-2,2-DIMETHYL-4,8,14-TRIOXO-12-THIA-5,9,15,19,24-PENTAAZAHEPTACOS-1-YL
[(2S,3R,4S,5S)-5-(6-AMINO-9H-PURIN-9-YL)-4-HYDROXY-3-(PHOSPHONOOXY)TETRAHYDROFURAN-2-YL]METHYL DIHYDROGEN DIPHOSPHATE | | Formula: | C33 H62 N11 O17 P3 S | | SMILES: | O=C(NCCCNCCCCNCCCN)CSCCNC(=O)CCNC(=O)C(O)C(C)(C)COP(=O)(O)OP(=O)(O)OCC3OC(n2cnc1c(ncnc12)N)C(O)C3OP(=O)(O)O | | InChi: | InChI=1S/C33H62N11O17P3S/c1-33(2,28(48)31(49)40-14-7-23(45)39-15-16-65-18-24(46)38-13-6-12-37-10-4-3-9-36-11-5-8-34)19-58-64(55,56)61-63(53,54)57-17-22-27(60-62(50,51)52)26(47)32(59-22)44-21-43-25-29(35)41-20-42-30(25)44/h20-22,26-28,32,36-37,47-48H,3-19,34H2,1-2H3,(H,38,46)(H,39,45)(H,40,49)(H,53,54)(H,55,56)(H2,35,41,42)(H2,50,51,52)/t22-,26-,27-,28+,32-/m1/s1 | | Synonyms: | N1-ACETYLSPERMINE-S-COA | | Definition date: | 2007-01-23 | | Last modified: | 2020-06-17 | | Identifier: | (3R)-27-amino-3-hydroxy-2,2-dimethyl-4,8,14-trioxo-12-thia-5,9,15,19,24-pentaazaheptacos-1-yl [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydrofuran-2-yl]methyl dihydrogen diphosphate (non-preferred name) |
|
 | | NHR | | Name: | 2-{4-[2-(2-AMINO-4-HYDROXY-QUINAZOLIN-6-YL)-1-CARBOXY-ETHYL]-BENZOYLAMINO}-PENTANEDIOIC ACID | | Formula: | C23 H22 N4 O8 | | SMILES: | O=C(O)C(NC(=O)c1ccc(cc1)C(C(=O)O)Cc3cc2c(nc(nc2O)N)cc3)CCC(=O)O | | InChi: | InChI=1S/C23H22N4O8/c24-23-26-16-6-1-11(10-15(16)20(31)27-23)9-14(21(32)33)12-2-4-13(5-3-12)19(30)25-17(22(34)35)7-8-18(28)29/h1-6,10,14,17H,7-9H2,(H,25,30)(H,28,29)(H,32,33)(H,34,35)(H3,24,26,27,31)/t14-,17+/m1/s1 | | Synonyms: | (10R)-10-FORMYL-5,8,10-TRIDEAZAFOLIC ACID | | Definition date: | 1999-07-30 | | Last modified: | 2020-06-17 | | Identifier: | N-({4-[(1R)-2-(2-amino-4-hydroxyquinazolin-6-yl)-1-carboxyethyl]phenyl}carbonyl)-L-glutamic acid |
|
 | | NHY | | Name: | N-HYDROXYUREA | | Formula: | C H4 N2 O2 | | SMILES: | O=C(N)NO | | InChi: | InChI=1S/CH4N2O2/c2-1(4)3-5/h5H,(H3,2,3,4) | | Synonyms: | 1-HYDROXYUREA | | Definition date: | 2006-03-22 | | Last modified: | 2020-06-17 | | Identifier: | 1-hydroxyurea |
|
 | | NIA | | Name: | ((2R,3S,4R,5R)-5-(5-AMINO-4-NITRO-1H-IMIDAZOL-1-YL)-3,4-DIHYDROXYTETRAHYDROFURAN-2-YL)METHYL DIHYDROGEN PHOSPHATE | | Formula: | C8 H13 N4 O9 P | | SMILES: | [O-][N+](=O)c1ncn(c1N)C2OC(C(O)C2O)COP(=O)(O)O | | InChi: | InChI=1S/C8H13N4O9P/c9-6-7(12(15)16)10-2-11(6)8-5(14)4(13)3(21-8)1-20-22(17,18)19/h2-5,8,13-14H,1,9H2,(H2,17,18,19)/t3-,4-,5-,8-/m1/s1 | | Synonyms: | 4-NITRO-5-AMINOIMIDAZOLE RIBONUCLEOTIDE | | Definition date: | 2005-09-07 | | Last modified: | 2020-06-17 | | Identifier: | 4-nitro-1-(5-O-phosphono-beta-D-ribofuranosyl)-1H-imidazol-5-amine |
|
 | | NIG | | Name: | N-(IMINOMETHYL)-L-GLUTAMIC ACID | | Formula: | C6 H10 N2 O4 | | SMILES: | O=C(O)CCC(NC=[N@H])C(=O)O | | InChi: | InChI=1S/C6H10N2O4/c7-3-8-4(6(11)12)1-2-5(9)10/h3-4H,1-2H2,(H2,7,8)(H,9,10)(H,11,12)/t4-/m0/s1 | | Synonyms: | N-FORMIMINO-L-GLUTAMATE | | Definition date: | 2007-05-10 | | Last modified: | 2020-06-17 | | Identifier: | N-[(Z)-iminomethyl]-L-glutamic acid |
|
 | | NIH | | Name: | 2-{[3,5-BIS(TRIFLUOROMETHYL)BENZYL]AMINO}-N-HYDROXY-6-OXO-1,6-DIHYDROPYRIMIDINE-5-CARBOXAMIDE | | Formula: | C14 H10 F6 N4 O3 | | SMILES: | FC(F)(F)c1cc(cc(c1)C(F)(F)F)CNC2=NC=C(C(=O)N2)C(=O)NO | | InChi: | InChI=1S/C14H10F6N4O3/c15-13(16,17)7-1-6(2-8(3-7)14(18,19)20)4-21-12-22-5-9(10(25)23-12)11(26)24-27/h1-3,5,27H,4H2,(H,24,26)(H2,21,22,23,25) | | Synonyms: | AZ12194344 | | Definition date: | 2005-10-17 | | Last modified: | 2020-06-17 | | Release date: | 2013-11-13 | | Identifier: | 2-{[3,5-bis(trifluoromethyl)benzyl]amino}-N-hydroxy-6-oxo-1,6-dihydropyrimidine-5-carboxamide |
|
 | | NIM | | Name: | 4-NITRO-2-PHENOXYMETHANESULFONANILIDE | | Formula: | C13 H12 N2 O5 S | | SMILES: | [O-][N+](=O)c2cc(Oc1ccccc1)c(cc2)NS(=O)(=O)C | | InChi: | InChI=1S/C13H12N2O5S/c1-21(18,19)14-12-8-7-10(15(16)17)9-13(12)20-11-5-3-2-4-6-11/h2-9,14H,1H3 | | Synonyms: | NIMESULIDE | | Definition date: | 2005-06-20 | | Last modified: | 2020-06-17 | | Identifier: | N-(4-nitro-2-phenoxyphenyl)methanesulfonamide |
|